YAN Er-kun. Primary study on animal test of 125I sealed seed source for tumor therapy[J]. Int J Radiat Med Nucl Med, 2005, 29(4): 161-163.
Citation: YAN Er-kun. Primary study on animal test of 125I sealed seed source for tumor therapy[J]. Int J Radiat Med Nucl Med, 2005, 29(4): 161-163.

Primary study on animal test of 125I sealed seed source for tumor therapy

  • Objective: To investigate antipersonnel effectiveness of Hela cell and therapeutic effectiveness of tumor of 125I sealed seed source. Method: 125I sealed seed source was implanted in tumor of bearingtumor mice, therapeutic effectiveness of tumor and toxicity of blood were observed. Result: 125I sealed seed source had antipersonnel effectiveness for Hela cell, and the range of antipersonnel effectiveness was 1.6~2.4mm after 48h irradiation, and controlled patently the growth of tumor, toxicity of blood was not found. Conclusion: 125I sealed seed source could control effectively the growth of tumor and obtain therapeutic purpose.
  • loading

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return